Maha Hussain

66PUBLICATIONS
509CO-AUTHORS
Molecular targetsMedical mycologyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Sep 29, 2026
Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic Therapies.

|Sep 10, 2026
Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression.

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Apr 27, 2026
Phase I Trial of Ipatasertib plus Atezolizumab Enhances PI3K/AKT Pathway Immune Responses in Solid Tumors and Refractory Glioblastoma.

|Feb 10, 2026
An Integrated Nonclinical and Clinical Risk Assessment of the Effects of Investigational ATRi Tuvusertib on QTc Interval in Patients With Solid Tumors.

Jatinder Kaur Mukker, Timothy A Yap, Anthony W Tolcher

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

Pageof 11

Frequent Collaborators

13 joint publications

Bora Gurel

10 joint publications

Susana Miranda

9 joint publications

Suzanne Carreira

9 joint publications

Jan Rekowski